137 related articles for article (PubMed ID: 35954372)
1. Adult Medulloblastoma: Updates on Current Management and Future Perspectives.
Franceschi E; Giannini C; Furtner J; Pajtler KW; Asioli S; Guzman R; Seidel C; Gatto L; Hau P
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954372
[TBL] [Abstract][Full Text] [Related]
2. The Alliance AMBUSH Trial: Rationale and Design.
Mahajan A; Shih H; Penas-Prado M; Ligon K; Aldape K; Hu LS; Loughan AR; Basso MR; Leeper HE; Nahed BV; Stott SL; Geyer S; Giannini C; Galanis E
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053576
[TBL] [Abstract][Full Text] [Related]
3. Updates on Management of Adult Medulloblastoma.
Majd N; Penas-Prado M
Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
[TBL] [Abstract][Full Text] [Related]
4. Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis.
Li Y; Song Q; Day BW
Acta Neuropathol Commun; 2019 Jul; 7(1):123. PubMed ID: 31362788
[TBL] [Abstract][Full Text] [Related]
5. Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?
Gatto L; Franceschi E; Tosoni A; Di Nunno V; Bartolini S; Brandes AA
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053495
[TBL] [Abstract][Full Text] [Related]
6. Complete and sustained response of adult medulloblastoma to first-line sonic hedgehog inhibition with vismodegib.
Lou E; Schomaker M; Wilson JD; Ahrens M; Dolan M; Nelson AC
Cancer Biol Ther; 2016 Oct; 17(10):1010-1016. PubMed ID: 27682250
[TBL] [Abstract][Full Text] [Related]
7. Management of children with primitive neuroectodermal tumors of the posterior fossa/medulloblastoma.
Packer RJ; Sutton LN; D'Angio G; Evans AE; Schut L
Pediatr Neurosci; 1985-1986; 12(4-5):272-82. PubMed ID: 3039477
[TBL] [Abstract][Full Text] [Related]
8. Sonic Hedgehog Medulloblastoma Cancer Stem Cells Mirnome and Transcriptome Highlight Novel Functional Networks.
Po A; Abballe L; Sabato C; Gianno F; Chiacchiarini M; Catanzaro G; De Smaele E; Giangaspero F; Ferretti E; Miele E; Besharat ZM
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096798
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma.
Kieran MW; Chisholm J; Casanova M; Brandes AA; Aerts I; Bouffet E; Bailey S; Leary S; MacDonald TJ; Mechinaud F; Cohen KJ; Riccardi R; Mason W; Hargrave D; Kalambakas S; Deshpande P; Tai F; Hurh E; Geoerger B
Neuro Oncol; 2017 Oct; 19(11):1542-1552. PubMed ID: 28605510
[TBL] [Abstract][Full Text] [Related]
10. Differential response of SHH-expressing adult medulloblastomas to the sonic hedgehog inhibitor vismodegib: whole-genome analysis.
Lou E; Nelson AC; Kool M
Cancer Biol Ther; 2019; 20(11):1398-1402. PubMed ID: 31423907
[TBL] [Abstract][Full Text] [Related]
11. SOX9 Defines Distinct Populations of Cells in SHH Medulloblastoma but Is Not Required for Math1-Driven Tumor Formation.
Adolphe C; Millar A; Kojic M; Barkauskas DS; Sundström A; Swartling FJ; Hediyeh-Zadeh S; Tan CW; Davis MJ; Genovesi LA; Wainwright BJ
Mol Cancer Res; 2021 Nov; 19(11):1831-1839. PubMed ID: 34330843
[TBL] [Abstract][Full Text] [Related]
12. Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.
Sursal T; Ronecker JS; Dicpinigaitis AJ; Mohan AL; Tobias ME; Gandhi CD; Jhanwar-Uniyal M
Anticancer Res; 2022 May; 42(5):2225-2239. PubMed ID: 35489737
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
[TBL] [Abstract][Full Text] [Related]
14. Identification of Let-7 miRNA Activity as a Prognostic Biomarker of SHH Medulloblastoma.
Westphal MS; Lee E; Schadt EE; Sholler GS; Zhu J
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008302
[TBL] [Abstract][Full Text] [Related]
15. Disruption of rack1 suppresses SHH-type medulloblastoma formation in mice.
Liu F; Shao J; Yang H; Yang G; Zhu Q; Wu Y; Zhu L; Wu H
CNS Neurosci Ther; 2021 Dec; 27(12):1518-1530. PubMed ID: 34480519
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa.
Packer RJ
Ann Neurol; 1990 Dec; 28(6):823-8. PubMed ID: 2178331
[TBL] [Abstract][Full Text] [Related]
17. Sonic Hedgehog Signaling in Cerebellar Development and Cancer.
Wang W; Shiraishi R; Kawauchi D
Front Cell Dev Biol; 2022; 10():864035. PubMed ID: 35573667
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.
Rodriguez-Blanco J; Pednekar L; Penas C; Li B; Martin V; Long J; Lee E; Weiss WA; Rodriguez C; Mehrdad N; Nguyen DM; Ayad NG; Rai P; Capobianco AJ; Robbins DJ
Oncogene; 2017 Nov; 36(45):6306-6314. PubMed ID: 28714964
[TBL] [Abstract][Full Text] [Related]
19. An ABC Transporter Drives Medulloblastoma Pathogenesis by Regulating Sonic Hedgehog Signaling.
Wijaya J; Vo BT; Liu J; Xu B; Wu G; Wang Y; Peng J; Zhang J; Janke LJ; Orr BA; Yu J; Roussel MF; Schuetz JD
Cancer Res; 2020 Apr; 80(7):1524-1537. PubMed ID: 31948942
[TBL] [Abstract][Full Text] [Related]
20. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
